If the choice is between drops and no treatment at all, drops are the clear winner
Saxenda is a GLP-1 receptor agonist that slows gastric emptying and reduces appetite, licensed for weight management in adults with obesity or overweight with comorbidities
Intermediate phase: weeks two through four More noticeable changes typically emerge during weeks two through four
Anti-setmelanotide antibodies prevalence by indication: BBS 3/50 (6.0%), AS 1/8 (12.5%), POMC deficiency (0/16), PCSK1 deficiency (0/2), LEPR deficiency (0/21), and acquired HO (0/142)
What GLP-1s Actually Are GLP-1 is a peptide hormone produced in the gut when you eat
The table's thyroid cancer history row says risk of recurrence with rapid weight loss or hormonal shifts requires oncology consultation, with oncology sign-off recommended